Ultragenyx Pharmaceutical Inc. (RARE) Social Stream
ULTRAGENYX PHARMACEUTICAL INC (RARE) Price Targets From Analysts
Use the tables below to see what analysts covering ULTRAGENYX PHARMACEUTICAL INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-05 | 16 | $185 | $73 | $146.2 | $48.47 | 201.63% |
| 2022-01-11 | 16 | $185 | $73 | $143.933 | $48.47 | 196.95% |
| 2022-01-25 | 16 | $185 | $73 | $143 | $48.47 | 195.03% |
| 2022-01-26 | 16 | $185 | $73 | $142.4 | $48.47 | 193.79% |
| 2022-01-31 | 16 | $185 | $73 | $140 | $48.47 | 188.84% |
| 2022-02-11 | 16 | $185 | $73 | $140 | $48.47 | 188.84% |
| 2022-02-14 | 15 | $185 | $73 | $139.466 | $48.47 | 187.74% |
| 2022-04-26 | 15 | $186 | $73 | $139.533 | $48.47 | 187.87% |
| 2022-04-28 | 15 | $186 | $73 | $139.666 | $48.47 | 188.15% |
| 2022-05-05 | 15 | $186 | $73 | $138.461 | $48.47 | 185.66% |
| 2022-05-09 | 13 | $186 | $71 | $129.538 | $48.47 | 167.25% |
| 2022-05-18 | 13 | $186 | $71 | $126.846 | $48.47 | 161.7% |
| 2022-05-24 | 14 | $186 | $71 | $125 | $48.47 | 157.89% |
| 2022-07-28 | 13 | $185 | $70 | $121.5 | $48.47 | 150.67% |
| 2022-08-01 | 14 | $185 | $68 | $117 | $48.47 | 141.39% |
| 2022-08-02 | 14 | $185 | $60 | $112.666 | $48.47 | 132.44% |
| 2022-08-13 | 14 | $185 | $60 | $114.5 | $48.47 | 136.23% |
The Trend in the Analyst Price Target
RARE's average price target has moved up $38.71 over the prior 27 months.
Over the past 49 weeks, RARE's average upside potential has been 107.19%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-31 | 16 | 185 | 73 | 140.000 | 69.93 | 100.2% |
| 2022-02-14 | 15 | 185 | 73 | 139.466 | 71.25 | 95.74% |
| 2022-04-26 | 15 | 186 | 73 | 139.533 | 70.74 | 97.25% |
| 2022-05-18 | 14 | 186 | 71 | 126.846 | 47.70 | 165.92% |
| 2022-08-13 | 13 | 185 | 60 | 117.266 | 51.57 | 127.39% |
RARE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.75 | 9 | 1 | 3 | 1 | 1 | 14 |
The Trend in the Broker Recommendations
RARE's average broker recommendation rating worsened by 0.29 over the prior 24 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ULTRAGENYX PHARMACEUTICAL INC's number of analysts covering the stock is greater than 1830.15% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the large market cap category, ULTRAGENYX PHARMACEUTICAL INC's upside potential (average analyst target price relative to current price) is greater than 1823.62% of them.
- RARE has a greater average analyst price target than 1787.46% of Pharmaceutical Products stocks.
- In the context of stocks in the large market cap category, ULTRAGENYX PHARMACEUTICAL INC's variance in analysts' estimates is lower than -1637.75% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ULTRAGENYX PHARMACEUTICAL INC are PRGO, NKTR, and MRVI.
View All Top Stocks by Price Target
Is RARE a Buy, Hold or Sell? See the POWR Ratings now!